{"transactions":[{"id":1034221,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-22T16:06:04.000Z","date":"2025-09-18","kind":"grant","planned":false,"acquired":true,"shares":39897,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 29,293 shares vested in full upon the date of grant and options to purchase 9,974 shares will vest in four substantially equal quarterly installments such that the stock option is fully vested on the first anniversary of the date of grant."}],"balance_after":39897,"derivative":{"exercise_price":1.93,"expiration_date":"2035-09-18","underlying":"Common Stock","underlying_shares":39897},"source":{"system":"sec-edgar","filing":"0001602459-25-000004","document":"wk-form4_1758571561.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602459/000160245925000004/wk-form4_1758571561.xml","form_type":"4"}},{"id":1054303,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-27T08:25:19.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":10276,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 6,933 shares vested in full upon the date of grant and options to purchase 3,343 shares will vest in four substantially equal quarterly installments such that the stock option is fully vested on the first anniversary of the date of grant."}],"balance_after":10276,"derivative":{"exercise_price":1.41,"expiration_date":"2035-08-26","underlying":"Common Stock","underlying_shares":10276},"source":{"system":"sec-edgar","filing":"0001824293-25-000143","document":"wk-form4_1756297514.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602459/000182429325000143/wk-form4_1756297514.xml","form_type":"4"}},{"id":1066120,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-14T16:58:19.000Z","date":"2025-08-13","kind":"grant","planned":false,"acquired":true,"shares":7545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 4 equal quarterly installments such that the stock option is fully vested on the first anniversary of the date of grant."}],"balance_after":7545,"derivative":{"exercise_price":1.3,"expiration_date":"2035-08-13","underlying":"Common Stock","underlying_shares":7545},"source":{"system":"sec-edgar","filing":"0001824293-25-000116","document":"wk-form4_1755205093.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602459/000182429325000116/wk-form4_1755205093.xml","form_type":"4"}},{"id":1295355,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-24T17:57:34.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":51937,"price":0.6857,"value":35613.2009,"ownership":{"direct":true},"balance_after":51937,"derivative":{"exercise_price":0.6857,"exercise_date":"2025-01-23","expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":51937},"source":{"system":"sec-edgar","filing":"0001824293-25-000030","document":"wk-form4_1737759448.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602459/000182429325000030/wk-form4_1737759448.xml","form_type":"4"}},{"id":1808195,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-14T16:10:06.000Z","date":"2023-08-10","kind":"grant","planned":false,"acquired":true,"shares":34483,"price":2.9,"value":100000.7,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests as to 1/12th of the underlying shares of common stock on the date of grant, then in 11 equal quarterly installments such that the stock option is fully vested on the third annual anniversary of the date of grant."}],"balance_after":34483,"derivative":{"exercise_price":2.9,"expiration_date":"2033-08-10","underlying":"Common Stock","underlying_shares":34483},"source":{"system":"sec-edgar","filing":"0001824293-23-000156","document":"wk-form4_1692043784.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602459/000182429323000156/wk-form4_1692043784.xml","form_type":"4"}},{"id":1829147,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2023-07-17T21:51:53.000Z","date":"2023-07-13","kind":"exercise","planned":false,"acquired":false,"shares":4564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":23372,"derivative":{"underlying":"Common Stock","underlying_shares":4564},"source":{"system":"sec-edgar","filing":"0001209191-23-042480","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123042480/doc4.xml","form_type":"4"}},{"id":1829146,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2023-07-17T21:51:53.000Z","date":"2023-07-13","kind":"exercise","planned":false,"acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":6250,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-23-042480","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123042480/doc4.xml","form_type":"4"}},{"id":1829145,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-07-17T21:51:53.000Z","date":"2023-07-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":2012,"price":1.31,"value":2635.72,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":33754,"source":{"system":"sec-edgar","filing":"0001209191-23-042480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123042480/doc4.xml","form_type":"4"}},{"id":1829144,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-07-17T21:51:53.000Z","date":"2023-07-13","kind":"exercise","planned":false,"acquired":true,"shares":4564,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":35766,"source":{"system":"sec-edgar","filing":"0001209191-23-042480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123042480/doc4.xml","form_type":"4"}},{"id":1829143,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-07-17T21:51:53.000Z","date":"2023-07-13","kind":"exercise","planned":false,"acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":31202,"source":{"system":"sec-edgar","filing":"0001209191-23-042480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123042480/doc4.xml","form_type":"4"}},{"id":1919238,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2023-04-17T21:28:47.000Z","date":"2023-04-13","kind":"exercise","planned":false,"acquired":false,"shares":4564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":27936,"derivative":{"underlying":"Common Stock","underlying_shares":4564},"source":{"system":"sec-edgar","filing":"0001209191-23-024500","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123024500/doc4.xml","form_type":"4"}},{"id":1919237,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2023-04-17T21:28:47.000Z","date":"2023-04-13","kind":"exercise","planned":false,"acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":7500,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-23-024500","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123024500/doc4.xml","form_type":"4"}},{"id":1919236,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-04-17T21:28:47.000Z","date":"2023-04-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":2012,"price":2.88,"value":5794.56,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":29952,"source":{"system":"sec-edgar","filing":"0001209191-23-024500","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123024500/doc4.xml","form_type":"4"}},{"id":1919235,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-04-17T21:28:47.000Z","date":"2023-04-13","kind":"exercise","planned":false,"acquired":true,"shares":4564,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":31964,"source":{"system":"sec-edgar","filing":"0001209191-23-024500","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123024500/doc4.xml","form_type":"4"}},{"id":1919234,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-04-17T21:28:47.000Z","date":"2023-04-13","kind":"exercise","planned":false,"acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":27400,"source":{"system":"sec-edgar","filing":"0001209191-23-024500","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123024500/doc4.xml","form_type":"4"}},{"id":2050109,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Performance Stock Units","published_at":"2023-01-20T22:10:40.000Z","date":"2023-01-18","kind":"grant","acquired":true,"shares":49788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 25, 2022, the Compensation Committee of the Issuer (the \"Committee\") granted the Reporting Person Performance Stock Units (\"PSUs\"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs are further subject to a time-based vesting schedule. The PSUs will vest in full on the first anniversary of the grant date subject to continued employment through such date. Upon vesting and settlement of the PSUs, the Reporting Person will receive a number of shares of common stock of the Issuer equal to the number of PSUs that have vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 25, 2022, the Compensation Committee of the Issuer (the \"Committee\") granted the Reporting Person Performance Stock Units (\"PSUs\"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs are further subject to a time-based vesting schedule. The PSUs will vest in full on the first anniversary of the grant date subject to continued employment through such date. Upon vesting and settlement of the PSUs, the Reporting Person will receive a number of shares of common stock of the Issuer equal to the number of PSUs that have vested."}],"balance_after":49788,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":49788},"source":{"system":"sec-edgar","filing":"0001209191-23-004304","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123004304/doc4.xml","form_type":"4"}},{"id":2054191,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2023-01-17T22:37:18.000Z","date":"2023-01-13","kind":"exercise","acquired":false,"shares":4564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":32500,"derivative":{"underlying":"Common Stock","underlying_shares":4564},"source":{"system":"sec-edgar","filing":"0001209191-23-003564","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003564/doc4.xml","form_type":"4"}},{"id":2054190,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2023-01-17T22:37:18.000Z","date":"2023-01-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":8750,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-23-003564","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003564/doc4.xml","form_type":"4"}},{"id":2054189,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-01-17T22:37:18.000Z","date":"2023-01-13","kind":"tax_withholding","acquired":false,"shares":2012,"price":3.17,"value":6378.04,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":26150,"source":{"system":"sec-edgar","filing":"0001209191-23-003564","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003564/doc4.xml","form_type":"4"}},{"id":2054188,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-01-17T22:37:18.000Z","date":"2023-01-13","kind":"exercise","acquired":true,"shares":4564,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":28162,"source":{"system":"sec-edgar","filing":"0001209191-23-003564","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003564/doc4.xml","form_type":"4"}},{"id":2054187,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-01-17T22:37:18.000Z","date":"2023-01-13","kind":"exercise","acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":23598,"source":{"system":"sec-edgar","filing":"0001209191-23-003564","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003564/doc4.xml","form_type":"4"}},{"id":2054186,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-01-17T22:37:18.000Z","date":"2022-10-31","kind":"other","acquired":true,"shares":1654,"price":3.2725,"value":5412.715,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on October 31, 2022."}],"balance_after":22348,"source":{"system":"sec-edgar","filing":"0001209191-23-003564","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003564/doc4.xml","form_type":"4"}},{"id":2136699,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2022-10-17T20:38:06.000Z","date":"2022-10-13","kind":"exercise","acquired":false,"shares":4564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":37064,"derivative":{"underlying":"Common Stock","underlying_shares":4564},"source":{"system":"sec-edgar","filing":"0001209191-22-053836","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122053836/doc4.xml","form_type":"4"}},{"id":2136698,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2022-10-17T20:38:06.000Z","date":"2022-10-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-22-053836","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122053836/doc4.xml","form_type":"4"}},{"id":2136697,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-10-17T20:38:06.000Z","date":"2022-10-13","kind":"tax_withholding","acquired":false,"shares":2012,"price":3.76,"value":7565.12,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":20694,"source":{"system":"sec-edgar","filing":"0001209191-22-053836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122053836/doc4.xml","form_type":"4"}},{"id":2136696,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-10-17T20:38:06.000Z","date":"2022-10-13","kind":"exercise","acquired":true,"shares":4564,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":22706,"source":{"system":"sec-edgar","filing":"0001209191-22-053836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122053836/doc4.xml","form_type":"4"}},{"id":2136695,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-10-17T20:38:06.000Z","date":"2022-10-13","kind":"exercise","acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":18142,"source":{"system":"sec-edgar","filing":"0001209191-22-053836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122053836/doc4.xml","form_type":"4"}},{"id":2201577,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-07-27T22:23:29.000Z","date":"2022-07-25","kind":"grant","acquired":true,"shares":165961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 8 equal quarterly installments beginning one quarter after the date of grant (07/25/2022)."}],"balance_after":165961,"derivative":{"exercise_price":3.17,"expiration_date":"2032-07-25","underlying":"Common Stock","underlying_shares":165961},"source":{"system":"sec-edgar","filing":"0001209191-22-043292","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122043292/doc4.xml","form_type":"4"}},{"id":2207309,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2022-07-15T20:58:24.000Z","date":"2022-07-13","kind":"exercise","acquired":false,"shares":4564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":41628,"derivative":{"underlying":"Common Stock","underlying_shares":4564},"source":{"system":"sec-edgar","filing":"0001209191-22-042263","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122042263/doc4.xml","form_type":"4"}},{"id":2207308,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2022-07-15T20:58:24.000Z","date":"2022-07-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":11250,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-22-042263","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122042263/doc4.xml","form_type":"4"}},{"id":2207307,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-07-15T20:58:24.000Z","date":"2022-07-13","kind":"tax_withholding","acquired":false,"shares":2012,"price":3.01,"value":6056.12,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":16892,"source":{"system":"sec-edgar","filing":"0001209191-22-042263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122042263/doc4.xml","form_type":"4"}},{"id":2207306,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-07-15T20:58:24.000Z","date":"2022-07-13","kind":"exercise","acquired":true,"shares":4564,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":18904,"source":{"system":"sec-edgar","filing":"0001209191-22-042263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122042263/doc4.xml","form_type":"4"}},{"id":2207305,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-07-15T20:58:24.000Z","date":"2022-07-13","kind":"exercise","acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":14340,"source":{"system":"sec-edgar","filing":"0001209191-22-042263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122042263/doc4.xml","form_type":"4"}},{"id":2207304,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-07-15T20:58:24.000Z","date":"2022-04-29","kind":"other","acquired":true,"shares":1505,"price":3.842,"value":5782.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 29, 2022."}],"balance_after":13090,"source":{"system":"sec-edgar","filing":"0001209191-22-042263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122042263/doc4.xml","form_type":"4"}},{"id":2296664,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2022-04-15T21:06:07.000Z","date":"2022-04-13","kind":"exercise","acquired":false,"shares":4564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":46192,"derivative":{"underlying":"Common Stock","underlying_shares":4564},"source":{"system":"sec-edgar","filing":"0001209191-22-024523","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122024523/doc4.xml","form_type":"4"}},{"id":2296663,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2022-04-15T21:06:07.000Z","date":"2022-04-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":12500,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-22-024523","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122024523/doc4.xml","form_type":"4"}},{"id":2296662,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-04-15T21:06:07.000Z","date":"2022-04-13","kind":"tax_withholding","acquired":false,"shares":2012,"price":6.07,"value":12212.84,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":11585,"source":{"system":"sec-edgar","filing":"0001209191-22-024523","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122024523/doc4.xml","form_type":"4"}},{"id":2296661,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-04-15T21:06:07.000Z","date":"2022-04-13","kind":"exercise","acquired":true,"shares":4564,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":13597,"source":{"system":"sec-edgar","filing":"0001209191-22-024523","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122024523/doc4.xml","form_type":"4"}},{"id":2296660,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-04-15T21:06:07.000Z","date":"2022-04-13","kind":"exercise","acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":9033,"source":{"system":"sec-edgar","filing":"0001209191-22-024523","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122024523/doc4.xml","form_type":"4"}},{"id":2435504,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2022-01-14T22:09:45.000Z","date":"2022-01-13","kind":"exercise","acquired":false,"shares":4564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant."}],"balance_after":50756,"derivative":{"underlying":"Common Stock","underlying_shares":4564},"source":{"system":"sec-edgar","filing":"0001209191-22-003364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122003364/doc4.xml","form_type":"4"}},{"id":2435503,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2022-01-14T22:09:45.000Z","date":"2022-01-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":13750,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-22-003364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122003364/doc4.xml","form_type":"4"}},{"id":2435502,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-01-14T22:09:45.000Z","date":"2022-01-13","kind":"tax_withholding","acquired":false,"shares":2012,"price":8.3,"value":16699.6,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":7783,"source":{"system":"sec-edgar","filing":"0001209191-22-003364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122003364/doc4.xml","form_type":"4"}},{"id":2435501,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-01-14T22:09:45.000Z","date":"2022-01-13","kind":"exercise","acquired":true,"shares":4564,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":9795,"source":{"system":"sec-edgar","filing":"0001209191-22-003364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122003364/doc4.xml","form_type":"4"}},{"id":2435500,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-01-14T22:09:45.000Z","date":"2022-01-13","kind":"exercise","acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":5231,"source":{"system":"sec-edgar","filing":"0001209191-22-003364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122003364/doc4.xml","form_type":"4"}},{"id":2542021,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2021-10-15T20:26:31.000Z","date":"2021-10-13","kind":"grant","acquired":true,"shares":55320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant."}],"balance_after":55320,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":55320},"source":{"system":"sec-edgar","filing":"0001209191-21-060553","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121060553/doc4.xml","form_type":"4"}},{"id":2542020,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-10-15T20:26:31.000Z","date":"2021-10-13","kind":"grant","acquired":true,"shares":92200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests and becomes exercisable monthly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that the stock option will be fully vested on the four year anniversary of the date of grant."}],"balance_after":92200,"derivative":{"exercise_price":10.55,"expiration_date":"2031-10-13","underlying":"Common Stock","underlying_shares":92200},"source":{"system":"sec-edgar","filing":"0001209191-21-060553","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121060553/doc4.xml","form_type":"4"}},{"id":2542019,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2021-10-15T20:26:31.000Z","date":"2021-10-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":15000,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-21-060553","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121060553/doc4.xml","form_type":"4"}},{"id":2542018,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-10-15T20:26:31.000Z","date":"2021-10-13","kind":"tax_withholding","acquired":false,"shares":433,"price":10.55,"value":4568.15,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":3981,"source":{"system":"sec-edgar","filing":"0001209191-21-060553","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121060553/doc4.xml","form_type":"4"}},{"id":2542017,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-10-15T20:26:31.000Z","date":"2021-10-13","kind":"exercise","acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":4414,"source":{"system":"sec-edgar","filing":"0001209191-21-060553","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121060553/doc4.xml","form_type":"4"}},{"id":2633554,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2021-07-15T20:52:24.000Z","date":"2021-07-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."}],"balance_after":16250,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-21-046791","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121046791/doc4.xml","form_type":"4"}},{"id":2633553,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-07-15T20:52:24.000Z","date":"2021-07-13","kind":"tax_withholding","acquired":false,"shares":433,"price":13.48,"value":5836.84,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":3164,"source":{"system":"sec-edgar","filing":"0001209191-21-046791","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121046791/doc4.xml","form_type":"4"}},{"id":2633552,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-07-15T20:52:24.000Z","date":"2021-07-13","kind":"exercise","acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":3597,"source":{"system":"sec-edgar","filing":"0001209191-21-046791","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121046791/doc4.xml","form_type":"4"}},{"id":2633551,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-07-15T20:52:24.000Z","date":"2021-04-30","kind":"other","acquired":true,"shares":1530,"price":13.8975,"value":21263.175,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2021."}],"balance_after":2347,"source":{"system":"sec-edgar","filing":"0001209191-21-046791","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121046791/doc4.xml","form_type":"4"}},{"id":2748992,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2021-04-15T20:55:51.000Z","date":"2021-04-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."}],"balance_after":17500,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-21-026845","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121026845/doc4.xml","form_type":"4"}},{"id":2748991,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-04-15T20:55:51.000Z","date":"2021-04-13","kind":"tax_withholding","acquired":false,"shares":433,"price":16.66,"value":7213.78,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":817,"source":{"system":"sec-edgar","filing":"0001209191-21-026845","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121026845/doc4.xml","form_type":"4"}},{"id":2748990,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-04-15T20:55:51.000Z","date":"2021-04-13","kind":"exercise","acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":1250,"source":{"system":"sec-edgar","filing":"0001209191-21-026845","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121026845/doc4.xml","form_type":"4"}},{"id":2906648,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2021-01-15T21:30:23.000Z","date":"2021-01-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."}],"balance_after":18750,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-21-003807","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121003807/doc4.xml","form_type":"4"}},{"id":2906647,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-01-15T21:30:23.000Z","date":"2021-01-14","kind":"sale","acquired":false,"shares":827,"price":18.0897,"value":14960.1819,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of November 30, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The range of sales prices received was $17.71 to $18.40. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-003807","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121003807/doc4.xml","form_type":"4"}},{"id":2906646,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-01-15T21:30:23.000Z","date":"2021-01-13","kind":"tax_withholding","acquired":false,"shares":423,"price":18.16,"value":7681.68,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":827,"source":{"system":"sec-edgar","filing":"0001209191-21-003807","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121003807/doc4.xml","form_type":"4"}},{"id":2906645,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-01-15T21:30:23.000Z","date":"2021-01-13","kind":"exercise","acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":1250,"source":{"system":"sec-edgar","filing":"0001209191-21-003807","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121003807/doc4.xml","form_type":"4"}},{"id":2912953,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":60554,"kind":"person","name":"Szekeres David Leslie","position":1,"cik":"0001602459","reported_name":"Szekeres David Leslie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-01-08T23:07:34.000Z","date":"2021-01-08","kind":"sale","acquired":false,"shares":3571,"price":19.6638,"value":70219.4298,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of November 30, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of sales prices received was $19.45 to $19.94. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-002806","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121002806/doc4.xml","form_type":"4"}}]}